Susceptibility to traditional first-line agents is improving, and multidrug resistance is low; however, fluoroquinolone resistance remains high. Ongoing AMR surveillance and prudent antibiotic use are essential to sustain treatment efficacy.
Sonal et al. (Tue,) studied this question.